🔎 Trials Near Me

Akèy › Kansè poumon › Illinois › Champaign

Etid klinik pou Kansè poumon nan Champaign, IL

9 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Champaign (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Ap rekriteFaz 3
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 70 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Ap rekriteFaz 3
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04181060

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Carle Cancer Center, Urbana · 2 mi lwen
18 Minutes · Tout sèks · Mizajou May 5, 2026 · NCT06031688

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Ap rekriteEtid obsèvasyon
  • Carle Cancer Center, Urbana · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jan 9, 2026 · NCT06073431

Etid Kansè poumon nan lòt vil

Lòt etid nan Champaign

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.